Back to Journals » Drug Design, Development and Therapy » Volume 11

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation

Total article views   Abstract views HTML views PDF downloads Totals
8,873 Dovepress* 7,259 1,297+ 1,386 8,556
PubMed Central* 0 317 96 317
Totals 7,259 1,614 1,482 8,873
*Since 17 January 2017
+Since July 2016

View citations on PubMed Central and Google Scholar